Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Respiratory Virus Vaccines Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Respiratory Virus Vaccines Market Analysis and Forecast, 2018–2030


5. Market Outlook

5.1. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)

5.2. Disease Prevalence & Incidence Rate globally with key countries

5.3. Pipeline Analysis

5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short-/Mid-/Long-term Impact) Pricing Analysis


6. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type

6.1. Introduction & Definition

6.2. Global Respiratory Virus Vaccines Market Value Forecast, by Type, 2018–2030

6.2.1. Inactivated/Killed Vaccines

6.2.2. Live-attenuated Vaccines

6.2.3. Recombinant vaccines

6.3. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Type


7. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Global Respiratory Virus Vaccines Market Value Forecast, by Route of Administration, 2018–2030

7.2.1. Intramuscular

7.2.2. Intranasal

7.2.3. Subcutaneous

7.3. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration


8. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication

8.1. Global Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

8.1.1. Influenza

8.1.2. Measles, Mumps & Rubella

8.1.3. Coronavirus Disease (COVID-19)

8.1.4. Others

8.2. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication


9. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group

9.1. Global Respiratory Virus Vaccines Market Value Forecast, by Age Group, 2018–2030

9.1.1. Pediatric

9.1.2. Adults

9.2. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group


10. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user

10.1. Global Respiratory Virus Vaccines Market Value Forecast, by End-user, 2018–2030

10.1.1. Physician’s Office

10.1.2. Hospitals

10.1.3. Clinics

10.1.4. Pharmacy/Store

10.1.5. Others

10.2. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user


11. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Region

11.1. Introduction

11.2. Global Respiratory Virus Vaccines Market Value Forecast, by Region, 2018–2030

11.2.1. North America

11.2.2. Europe

11.2.3. Asia Pacific

11.2.4. Latin America

11.2.5. Middle East & Africa

11.3. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Region


12. North America Respiratory Virus Vaccines Market Analysis and Forecast

12.1. Introduction

12.2. North America Respiratory Virus Vaccines Market Value Forecast, by Type, 2018–2030

12.2.1. Inactivated/Killed Vaccines

12.2.2. Live-attenuated Vaccines

12.2.3. Recombinant vaccines

12.3. North America Respiratory Virus Vaccines Market Value Forecast, by Route of Administration, 2018–2030

12.3.1. Intramuscular

12.3.2. Intranasal

12.3.3. Subcutaneous

12.4. North America Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

12.4.1. Influenza

12.4.2. Measles, Mumps & Rubella

12.4.3. Coronavirus Disease (COVID-19)

12.4.4. Others

12.5. North America Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

12.5.1. Pediatric

12.5.2. Adults

12.6. North America Respiratory Virus Vaccines Market Value Forecast, by End-user, 2018–2030

12.6.1. Physician Offices

12.6.2. Hospitals

12.6.3. Clinics

12.6.4. Pharmacy/Store

12.6.5. Others

12.7. North America Respiratory Virus Vaccines Market Value Forecast, by Country, 2018–2030

12.7.1. U.S.

12.7.2. Canada

12.8. North America Respiratory Virus Vaccines Market Attractiveness Analysis

12.8.1. By Type

12.8.2. By Route of Administration

12.8.3. By Indication

12.8.4. By Age Group

12.8.5. By End-user

12.8.6. By Country


13. Europe Respiratory Virus Vaccines Market Analysis and Forecast

13.1. Introduction

13.2. Europe Respiratory Virus Vaccines Market Value Forecast, by Type, 2018–2030

13.2.1. Inactivated/Killed Vaccines

13.2.2. Live-attenuated Vaccines

13.2.3. Recombinant vaccines

13.3. Europe Respiratory Virus Vaccines Market Value Forecast, by Route of Administration, 2018–2030

13.3.1. Intramuscular

13.3.2. Intranasal

13.3.3. Subcutaneous

13.4. Europe Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

13.4.1. Influenza

13.4.2. Measles, Mumps & Rubella

13.4.3. Coronavirus Disease (COVID-19)

13.4.4. Others

13.5. Europe Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

13.5.1. Pediatric

13.5.2. Adults

13.6. Europe Respiratory Virus Vaccines Market Value Forecast, by End-user, 2018–2030

13.6.1. Physician Offices

13.6.2. Hospitals

13.6.3. Clinics

13.6.4. Pharmacy/Store

13.6.5. Others

13.7. Europe Respiratory Virus Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

13.7.1. Germany

13.7.2. U.K.

13.7.3. France

13.7.4. Spain

13.7.5. Italy

13.7.6. Rest of Europe

13.8. Europe Respiratory Virus Vaccines Market Attractiveness Analysis

13.8.1. By Type

13.8.2. By Route of Administration

13.8.3. By Indication

13.8.4. By Age Group

13.8.5. By End-user

13.8.6. By Country/Sub-region

14. Asia Pacific Respiratory Virus Vaccines Market Analysis and Forecast

14.1. Introduction

14.2. Asia Pacific Respiratory Virus Vaccines Market Value Forecast, by Type, 2018–2030

14.2.1. Inactivated/Killed Vaccines

14.2.2. Live-attenuated Vaccines

14.2.3. Recombinant vaccines

14.3. Asia Pacific Respiratory Virus Vaccines Market Value Forecast, by Route of Administration, 2018–2030

14.3.1. Intramuscular

14.3.2. Intranasal

14.3.3. Subcutaneous

14.4. Asia Pacific Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

14.4.1. Influenza

14.4.2. Measles, Mumps & Rubella

14.4.3. Coronavirus Disease (COVID-19)

14.4.4. Others

14.5. Asia Pacific Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

14.5.1. Pediatric

14.5.2. Adults

14.6. Asia Pacific Respiratory Virus Vaccines Market Value Forecast, by End-user, 2018–2030

14.6.1. Physician Offices

14.6.2. Hospitals

14.6.3. Clinics

14.6.4. Pharmacy/Store

14.6.5. Others

14.7. Asia Pacific Respiratory Virus Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

14.7.1. Japan

14.7.2. China

14.7.3. India

14.7.4. Australia & New Zealand

14.7.5. Rest of Asia Pacific

14.8. Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis

14.8.1. By Type

14.8.2. By Route of Administration

14.8.3. By Indication

14.8.4. By Age Group

14.8.5. By End-user

14.8.6. By Country/Sub-region

15. Latin America Respiratory Virus Vaccines Market Analysis and Forecast

15.1. Introduction

15.2. Latin America Respiratory Virus Vaccines Market Value Forecast, by Type, 2018–2030

15.2.1. Inactivated/Killed Vaccines

15.2.2. Live-attenuated Vaccines

15.2.3. Recombinant vaccines

15.3. Latin America Respiratory Virus Vaccines Market Value Forecast, by Route of Administration, 2018–2030

15.3.1. Intramuscular

15.3.2. Intranasal

15.3.3. Subcutaneous

15.4. Latin America Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

15.4.1. Influenza

15.4.2. Measles, Mumps & Rubella

15.4.3. Coronavirus Disease (COVID-19)

15.4.4. Others

15.5. Latin America Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

15.5.1. Pediatric

15.5.2. Adults

15.6. Latin America Respiratory Virus Vaccines Market Value Forecast, by End-user, 2018–2030

15.6.1. Physician Offices

15.6.2. Hospitals

15.6.3. Clinics

15.6.4. Pharmacy/Store

15.6.5. Others

15.7. Latin America Respiratory Virus Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

15.7.1. Brazil

15.7.2. Mexico

15.7.3. Rest of Latin America

15.8. Latin America Respiratory Virus Vaccines Market Attractiveness Analysis

15.8.1. By Type

15.8.2. By Route of Administration

15.8.3. By Indication

15.8.4. By Age Group

15.8.5. By End-user

15.8.6. By Country/Sub-region


16. Middle East & Africa Respiratory Virus Vaccines Market Analysis and Forecast

16.1. Introduction

16.2. Middle East & Africa Respiratory Virus Vaccines Market Value Forecast, by Type, 2018–2030

16.2.1. Inactivated/Killed Vaccines

16.2.2. Live-attenuated Vaccines

16.2.3. Recombinant vaccines

16.3. Middle East & Africa Respiratory Virus Vaccines Market Value Forecast, by Route of Administration , 2018–2030

16.3.1. Intramuscular

16.3.2. Intranasal

16.3.3. Subcutaneous

16.4. Middle East & Africa Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

16.4.1. Influenza

16.4.2. Measles, Mumps & Rubella

16.4.3. Coronavirus Disease (COVID-19)

16.4.4. Others

16.5. Middle East & Africa Respiratory Virus Vaccines Market Value Forecast, by Indication, 2018–2030

16.5.1. Pediatric

16.5.2. Adults

16.6. Middle East & Africa Respiratory Virus Vaccines Market Value Forecast, by End-user, 2018–2030

16.6.1. Physician Offices

16.6.2. Hospitals

16.6.3. Clinics

16.6.4. Pharmacy/Store

16.6.5. Others

16.7. Middle East & Africa Respiratory Virus Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

16.7.1. GCC Countries

16.7.2. South Africa

16.7.3. Rest of Middle East & Africa

16.8. Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis

16.8.1. By Type

16.8.2. By Route of Administration

16.8.3. By Indication

16.8.4. By Age Group

16.8.5. By End-user

16.8.6. By Country/Sub-region


17. Competition Landscape

17.1. Market Player - Competition Matrix (by tier and size of companies)

17.2. Global Respiratory Virus Vaccines Market Position Analysis, by Company, 2019

17.3. Company Profiles

17.3.1. CSL Limited

17.3.1.1. Company Description

17.3.1.2. Business Overview

17.3.1.3. Financial Overview

17.3.1.4. Strategic Overview

17.3.1.5. SWOT Analysis

17.3.2. Sanofi

17.3.2.1. Company Description

17.3.2.2. Business Overview

17.3.2.3. Financial Overview

17.3.2.4. Strategic Overview

17.3.2.5. SWOT Analysis

17.3.3. AstraZeneca

17.3.3.1. Company Description

17.3.3.2. Business Overview

17.3.3.3. Financial Overview

17.3.3.4. Strategic Overview

17.3.3.5. SWOT Analysis

17.3.4. Merck & Co., Inc.

17.3.4.1. Company Description

17.3.4.2. Business Overview

17.3.4.3. Strategic Overview

17.3.4.4. Financial Overview

17.3.4.5. SWOT Analysis

17.3.5. GlaxoSmithKline plc

17.3.5.1. Company Description

17.3.5.2. Business Overview

17.3.5.3. Strategic Overview

17.3.5.4. Financial Overview

17.3.5.5. SWOT Analysis

17.3.6. Serum Institute of India Pvt. Ltd.

17.3.6.1. Company Description

17.3.6.2. Business Overview

17.3.6.3. Financial Overview

17.3.6.4. Strategic Overview

17.3.6.5. SWOT Analysis

17.3.7. Bharat Biotech

17.3.7.1. Company Description

17.3.7.2. Business Overview

17.3.7.3. Financial Overview

17.3.7.4. Strategic Overview

17.3.7.5. SWOT Analysis

17.3.8. Sinovac Biotech Ltd.

17.3.8.1. Company Description

17.3.8.2. Business Overview

17.3.8.3. Financial Overview

17.3.8.4. Strategic Overview

17.3.8.5. SWOT Analysis



List of Figures



Figure 01 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030

Figure 02 Global Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 03 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030

Figure 04 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Inactivated/Killed Vaccines, 2018-2030

Figure 05 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Live-attenuated Vaccines, 2018-2030

Figure 06 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant vaccines, 2018-2030

Figure 07 Global Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 08 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030

Figure 09 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Intramuscular, 2018-2030

Figure 10 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Intranasal, 2018-2030

Figure 11 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Subcutaneous, 2018-2030

Figure 12 Global Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 13 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030

Figure 14 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Influenza, 2018-2030

Figure 15 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Measles, Mumps & Rubella, 2018-2030

Figure 16 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Coronavirus Disease (COVID-19), 2018-2030

Figure 17 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030

Figure 18 Global Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 19 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030

Figure 20 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Pediatric, 2018-2030

Figure 21 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Adult, 2018-2030

Figure 22 Global Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 23 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030

Figure 24 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2018-2030

Figure 25 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2018-2030

Figure 26 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2018-2030

Figure 27 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Pharmacy/Store, 2018-2030

Figure 28 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030

Figure 29 Global Respiratory Virus Vaccines Market Value Share Analysis, by Region, 2019 and 2030

Figure 30 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Region, 2020-2030

Figure 31 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030

Figure 32 North America Respiratory Virus Vaccines Market Value Share Analysis, by Country, 2019 and 2030

Figure 33 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Country, 2020-2030

Figure 34 North America Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 35 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030

Figure 36 North America Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 37 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030

Figure 38 North America Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 39 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030

Figure 40 North America Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 41 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030

Figure 42 North America Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 43 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030

Figure 44 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030

Figure 45 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 46 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Country, 2020-2030

Figure 47 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 48 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030

Figure 49 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 50 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030

Figure 51 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 52 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030

Figure 53 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 54 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030

Figure 55 Europe Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 56 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030

Figure 57 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030

Figure 58 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 59 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020-2030

Figure 60 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 61 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030

Figure 62 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 63 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030

Figure 64 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 65 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030

Figure 66 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 67 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030

Figure 68 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 69 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030

Figure 70 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030

Figure 71 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 72 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020-2030

Figure 73 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 74 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030

Figure 75 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 76 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030

Figure 77 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 78 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030

Figure 79 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 80 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030

Figure 81 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 82 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030

Figure 83 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030

Figure 84 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 85 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020-2030

Figure 86 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 87 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030

Figure 88 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 89 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030

Figure 90 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 91 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030

Figure 92 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 93 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030

Figure 94 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 95 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030


List of Tables



Table 01 Pipeline Analysis (1/4)

Table 02 Pipeline Analysis (2/4)

Table 03 Pipeline Analysis (3/4)

Table 04 Pipeline Analysis (4/4)

Table 05 Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (1/3)

Table 06 Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (2/3)

Table 07 Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (3/3)

Table 08 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 09 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 10 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 11 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 12 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 14 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 15 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 16 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 17 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 18 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 19 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 20 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 22 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 23 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 24 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 25 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 26 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 28 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 29 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 30 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 31 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 32 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 34 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 35 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 36 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 37 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 38 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 39 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 40 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 41 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 42 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 43 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030